相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CONVERSION TO AFLIBERCEPT THERAPY VERSUS CONTINUING WITH RANIBIZUMAB THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION DEPENDENT ON MONTHLY RANIBIZUMAB TREATMENT
Irmela Mantel et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2016)
A model of the ocular pharmacokinetics involved in the therapy of neovascular age-related macular degeneration with ranibizumab
Derek J. Saunders et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2015)
Suppression of Intraocular Vascular Endothelial Growth Factor During Aflibercept Treatment of Age-Related Macular Degeneration
Sascha Fauser et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2014)
Long-term Stability of Vascular Endothelial Growth Factor Suppression Time Under Ranibizumab Treatment in Age-Related Macular Degeneration
Philipp S. Muether et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2013)
Long-term effects of ranibizumab treatment delay in neovascular age-related macular degeneration
Philipp S. Muether et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2013)
Vascular Endothelial Growth Factor in Patients with Exudative Age-related Macular Degeneration Treated with Ranibizumab
Philipp S. Muether et al.
OPHTHALMOLOGY (2012)
Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
Jeffrey S. Heier et al.
OPHTHALMOLOGY (2012)
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration The CATT Research Group
Daniel F. Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Pharmacokinetics of intravitreal bevackumab (avastin)
Sophie J. Bakri et al.
OPHTHALMOLOGY (2007)
Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema
H Funatsu et al.
OPHTHALMOLOGY (2005)
分享论文
